-
<![CDATA[1 in 10 U.S. Adults Have Physician-Diagnosed Chronic Hand Eczema, Study Shows | Fall Clinical Derm 2025]]>
25 Oct 2025 03:53 GMT
… release announcing the result from LEO Pharma.
“These highly powered survey results … of North America Medical Affairs, LEO Pharma, in a news release. “This …
-
<![CDATA[LEO Pharma Finalizes Acquisition of Spesolimab for GPP]]>
03 Oct 2025 21:37 GMT
… the third strategic brand within LEO Pharma’s global dermatology portfolio.1 …
“With our specialization in dermatology, LEO Pharma is uniquely positioned to take … IL-36-mediated dermatoses.5
LEO Pharma will assume responsibility for commercialization …
-
LEO Pharma Presents Late-Breaking Results on Temtokibart for Atopic Dermatitis at EADV
18 Sep 2025 17:11 GMT
… Annual Meeting in Paris, France, LEO Pharma presented two late-breaking abstracts … advantages in specificity and safety. LEO Pharma has obtained a worldwide exclusive … , Science, Search & Innovation at LEO Pharma.
References
1. Weidinger S, et …
-
#EADV25: Leo Pharma details mid-stage win for IL-22 targeting antibody in atopic dermatitis
17 Sep 2025 14:19 GMT
-
Complete hair regrowth for some with alopecia after 3-year ritlecitinib treatment
23 Oct 2025 20:23 GMT
… Company, Incyte Corp, Janssen Pharmaceuticals, LEO Pharma, Merck, Otsuka/Visterra Inc …
-
LEO Pharma Delivers 7% Revenue Growth at CER in H1 2025 and Achieves Key Milestones Enabling Future Growth
18 Aug 2025 10:58 GMT
… marked major strategic milestones demonstrating LEO Pharma’s commitment to advancing innovation … 977
(761)
N.m.
About LEO Pharma
LEO Pharma is a global leader in … : BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: LEO Pharma
Copyright Business Wire 2025.
PUB …
-
Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24+ Companies and 26+ Therapies | DelveInsight
23 Oct 2025 17:00 GMT
… Pharmaceutical Technology Co., Ltd, LEO Pharma, Corvus Pharmaceuticals, Inc., … companies, including Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM … and others. Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM …
-
Nemolizumab Maintains Long-Term Safety and Efficacy in AD
23 Oct 2025 12:53 GMT
… , Beiersdorf, Eli Lilly, Galderma, Incyte, LEO Pharma, L'Oréal, Novartis, Pfizer …
-
LEO Pharma’s Robert Spurr on Delgocitinib Cream’s Approval and the Future of Chronic Hand Eczema
30 Jul 2025 14:22 GMT
… approval of delgocitinib cream (Anzupgo; LEO Pharma) for the treatment of moderate … and Support for Patients
As LEO Pharma moves forward with commercialization, patient … the immediate approval for CHE, LEO Pharma is already exploring additional indications …
-
Biologics in Patients With Psoriasis: Cancer Risks Compared
23 Oct 2025 07:06 GMT
… Johnson & Johnson, AbbVie, Novartis, LEO Pharma, and several other drug companies …
About
© 1995-2025